Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
YorLabs
AddedFeb 17, 2024
UpdatedJun 18, 2026
YorLabs

YorLabs

Series B

Yorlabs: Revolutionizing ultrasound imaging with pocket-sized, wireless probes and cost-effective SEU technology.

HQ
Portland, OR, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize ultrasound imaging, YorLabs offers a groundbreaking solution in the form of a pocket-sized, wireless probe. Their core vision is to simplify and enhance medical imaging through their Software Enabled Ultrasound (SEU) technology, which provides extensive capabilities without the need for costly device replacements. YorLabs primarily focuses on interventional cardiology (IC) and electrophysiology (EP), addressing the inefficiencies and high costs associated with traditional ultrasound systems.

YorLabs has attracted notable investors and industry experts who recognize the transformative potential of their technology. The company has achieved significant milestones, including the development of their innovative ICE system, which sets a new standard in intracardiac image-guided therapy. By reducing workflow inefficiencies and procedural complexities, YorLabs has made a substantial impact on the medical imaging market, offering a cost-effective and efficient alternative to existing systems.

YorLabs - Similar Companies

Exo logo

Exo

exo.inc

Sonosite logo

Sonosite

sonosite.com

Vave Health logo

Vave Health

vavehealth.com

SonoSolve logo

SonoSolve

Waveclear logo

Waveclear

Physiosonics logo

Physiosonics

Cephasonics logo

Cephasonics

cephasonics.com

EchoPixel logo

EchoPixel

echopixeltech.com

Auricle logo

Auricle

auricle.com

Liv Labs logo

Liv Labs

livlabsfitness.com

iSono Health logo

iSono Health

isonohealth.com

Morphle Labs logo

Morphle Labs

morphlelabs.com

Corveus Medical logo

Corveus Medical

corveusmedical.com

V-Flow Medical logo

V-Flow Medical

Digital Medical Tech logo

Digital Medical Tech

YorLabs - Quick Facts

Who are YorLabs' competitors?

Companies similar to YorLabs include Exo, Sonosite, Vave Health and SonoSolve.

When was YorLabs founded?

YorLabs was founded in 2015.

Where is YorLabs' headquarters located?

YorLabs' headquarters is located in Portland, OR, US.

When was YorLabs' last funding round?

YorLabs' most recent funding round was for $17.3M (USD) in October 2023.

How much has YorLabs raised to-date?

As of Oct 31, 2023, YorLabs has raised a total of $35.2M (USD).

How many employees does YorLabs have?

YorLabs has 25 employees as of Feb 5, 2024.

YorLabs - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Medical Imaging
  • Wireless
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
  • Ultrasound
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified